The effect of cassia fistula product

The comparison of effect of the topical product of Cassia fistula on diaper rash of infants in comparison with hydrocortisone: a double-blind clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230314057713N1

Enrollment

138

Registered

2023-04-07

Start date

2023-04-03

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation of the diaper area.

Interventions

Intervention 1: Intervention group: The evaluation of people entering the study is done by a doctor specializing in children and infants, and in case of clinical suspicion that there is a severe disea

Eligibility

Sex/Gender

All

Age

1 Days to 2 Years

Inclusion criteria

Inclusion criteria: Infants under two years old age Inflammation of diaper area

Exclusion criteria

Exclusion criteria: Atopic dermatitis and other skin dermatitis Other diaper rash treatment from 2 weeks ago Sever type or inflammation with above score 3 Drug sensivity Diarrhea Oral antibiotic consumption

Design outcomes

Primary

Measure	Time frame
Duration of treatment. Timepoint: each day. Method of measurement: Counting days.;Intensity of redness. Timepoint: Counting days. Method of measurement: diaper dermatitis severity index score.;The extent of redness. Timepoint: Counting days. Method of measurement: Percentage of diaper area.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ali Muzaffarpour

Babol University of Medical Sciences

Seyyedali1357@gmail.com+98 11 3219 9592

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026